Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Regulatory Filings 2007

Jan 10, 2007

29777_rns_2007-01-10_4f5d7cc5-54c2-4b91-832a-2230cc0c1b4c.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-A12B/A 1 a07-1548_38a12ba.htm AMENDMENT TO 8-A12B

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A/A

AMENDMENT NO. 1

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12 (b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

*ABBOTT LABORATORIES*

(Exact name of registrant as specified in its charter)

Illinois 36-0698440
(State of
incorporation or organization) (I.R.S. Employer
Identification No.)
100
Abbott Park Road, Abbott Park, Illinois 60064-6400
(Address of
principal executive offices) (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

| Title of each class | Name of each
exchange on which |
| --- | --- |
| to be so
registered: | each class is to
be registered: |
| Preferred
Stock Purchase Rights | New
York Stock Exchange, Inc. |
| | Chicago
Stock Exchange, Inc. |
| | NYSE
Arca, Inc. |

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x

If this Form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. o

Securities Act registration statement file number to which this form relates: None (if applicable)

Securities to be registered pursuant to Section 12(g) of the Act:

*None*

(Title of Class)

SEQ.=1,FOLIO='',FILE='C:\fc\915581015_D10967_1601146\1548-3-ba.htm',USER='jmsproofassembler',CD='Jan 9 15:58 2007'

*Item 1. Description of Registrant’s Securities to be Registered.*

Effective as of December 8, 2006, Abbott Laboratories, an Illinois corporation (the “ Company ”), adopted Amendment Number 3 (“ Amendment Number 3 ”), dated as of the same date, to the Rights Agreement, dated as of November 11, 1999, by and between the Company and Computershare Trust Company, N.A. (successor in interest to BankBoston, N.A.), (the “ Rights Agent ”), as amended by Amendment Number 1, dated as of December 7, 1999, and Amendment Number 2, dated as of May 19, 2000 (as so amended, the “ Rights Agreement ”). Amendment Number 3 changed the expiration date of the Company’s preferred stock purchase rights (the “ Rights ”) issued under the Rights Agreement from the close of business on November 10, 2009, to the close of business on December 11, 2006. As a result of Amendment Number 3, all Rights outstanding under the Rights Agreement expired as of the close of business on December 11, 2006.

The foregoing summary description of Amendment Number 3 is qualified in its entirety by reference to Amendment Number 3. A copy of Amendment Number 3 was filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 13, 2006, and is incorporated herein by reference.

*Item 2. Exhibits.*

Exhibit No. Description
1 Amendment Number 3 to Rights Agreement, dated as of
December 8, 2006, by and between Abbott Laboratories and Computershare Trust
Company, N.A. (successor in interest to BankBoston, N.A.), as Rights Agent
(filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with
the Securities and Exchange Commission on December 13, 2006)

2

SEQ.=1,FOLIO='2',FILE='C:\fc\10115342438_D11055_1603057\1548-3-da.htm',USER='jmsproofassembler',CD='Jan 10 11:53 2007'

*SIGNATURE*

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

/s/ Thomas C. Freyman
Name: Thomas C. Freyman
Title: Executive Vice President, Finance and Chief Financial Officer

3

SEQ.=1,FOLIO='3',FILE='C:\fc\10115342438_D11055_1603057\1548-3-da.htm',USER='jmsproofassembler',CD='Jan 10 11:53 2007'

*EXHIBIT INDEX*

Exhibit No. Description
1 Amendment Number 3 to Rights Agreement, dated as of
December 8, 2006, by and between Abbott Laboratories and Computershare Trust
Company, N.A. (successor in interest to BankBoston, N.A.), as Rights Agent
(filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with
the Securities and Exchange Commission on December 13, 2006)

SEQ.=1,FOLIO='',FILE='C:\fc\9161315934_D10967_1601165\1548-3-dc.htm',USER='jmsproofassembler',CD='Jan 9 16:13 2007'